Decoupling shear stress and pressure effects in the biomechanics of autosomal dominant polycystic kidney disease using a perfused kidney-on-chip
Acta Biomaterialia · 2025-05 · 197 · 326-338
DOI: 10.1016/j.actbio.2025.03.022 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Biomaterialia, 2025-05. Verfasst von Brice Lapin und 6 weiteren Autor:innen. Beteiligte Einrichtung: Institut Curie, Université PSL, Sorbonne Université, CNRS UMR168, Laboratoire Physique des Cellules et Cancer, Paris 75005, France. Hauptthemen laut MEDLINE: Polycystic Kidney, Autosomal Dominant, Stress, Mechanical, Kidney, Perfusion. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: European Commission, Foundation for Medical Research, LabEx CellnScale.
Abstract (Originalsprache)
Kidney tubular cells are submitted to two distinct mechanical forces generated by the urine flow: shear stress and hydrostatic pressure. In addition, the mechanical properties of the surrounding extracellular matrix modulate tubule deformation under constraints. These mechanical factors likely play a role in the pathophysiology of kidney as exemplified by autosomal dominant polycystic kidney disease, in which pressure, flow and matrix stiffness have been proposed to modulate the cystic dilation of tubules with PKD1 mutations. The lack of in vitro systems recapitulating the mechanical environment of kidney tubules impedes our ability to dissect the role of these mechanical factors. Here we describe a perfused kidney-on-chip with tunable extracellular matrix mechanical properties and hydrodynamic constraints, that allows a decoupling of shear stress and flow. We used this system to dissect how these mechanical cues affect Pkd1-/- tubule dilation. We investigated cell behavior for a flow shear stress of 1 dyn/cm², combined or not with a 10-mbar intraluminal pressure. Our results showed two distinct mechanisms leading to tubular dilation. For Pkd1-/- PCT cells (proximal tubule), overproliferation mechanically leads to tubular dilation of 1.5-2-fold in 5 days, regardless of the mechanical context. For mIMCD-3 cells (collecting duct), tube dilation was associated with a squamous cell morphology but not with overproliferation and was highly sensitive to extracellular matrix properties, with suppression of the dilation when switching extracellular matrix composition from 6 to 9 mg/ml collagen. Contrary to PCT, mIMCD-3 tube dilation was highly sensitive to the nature of hydrodynamic constraint. Surprisingly, flow alone suppressed Pkd1-/- mIMCD-3 tubule dilation observed in static conditions, while the addition of luminal pressure restored it. Our in vitro model emulating nephron geometrical and mechanical organization sheds light on the roles of mechanical constraints in ADPKD and demonstrates the importance of controlling intraluminal pressure in kidney tubule models. STATEMENT OF SIGNIFICANCE: In autosomal dominant polycystic kidney disease, the development of numerous renal cysts leads to renal failure, with no curative therapy available. The initial stage of cyst formation, local tubule dilation, remains poorly understood. Although mechanical cues may be decisive, there is a lack of biomimetic systems recapitulating them. Here, an innovative kidney-on-a-chip was designed to decouple different hydrodynamic cues. We observed disease-specific tube dilation, driven by distinct mechanisms based or not on proliferation, in proximal tubule or collecting duct cell lines. Strikingly in the latter case, dilation, highly dependent on mechanical conditions, was suppressed by flow but restored by luminal pressure. Our model highlights the role of mechanical constraints in ADPKD and the importance of pressure control in renal models.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institut Curie, Université PSL, Sorbonne Université, CNRS UMR168, Laboratoire Physique des Cellules et Cancer, Paris 75005, France.
- Université de Paris Cité, Institut Necker Enfants Malades-INEM, Département 'Croissance et Signalisation', INSERM UMR1151, CNRS UMR 8253, Paris, France.
- Université de Paris Cité, Institut Necker Enfants Malades-INEM, Département 'Croissance et Signalisation', INSERM UMR1151, CNRS UMR 8253, Paris, France; Service de Physiologie Hôpital Necker Enfants-Malades, Assistance…
- Institut Curie, Université PSL, Sorbonne Université, CNRS UMR168, Laboratoire Physique des Cellules et Cancer, Paris 75005, France. Electronic address: Stephanie.Descroix@curie.fr.
- Institut Curie, Université PSL, Sorbonne Université, CNRS UMR168, Laboratoire Physique des Cellules et Cancer, Paris 75005, France. Electronic address: Sylvie.Coscoy@curie.fr.
Förderung
- European Commission
- Foundation for Medical Research
- LabEx CellnScale
- Sorbonne Université
- Institut Pierre-Gilles de Gennes
- Institut Curie
- Centre National de la Recherche Scientifique
- Ministère de l'Enseignement supérieur et de la Recherche
Zitieren
APA
Lapin, B., Vandensteen, J., Gropplero, G., Mazloum, M., Bienaimé, F., Descroix, S., & Coscoy, S. (2025). Decoupling shear stress and pressure effects in the biomechanics of autosomal dominant polycystic kidney disease using a perfused kidney-on-chip. Acta Biomaterialia, 197, 326-338. https://doi.org/10.1016/j.actbio.2025.03.022
Vancouver
Lapin B, Vandensteen J, Gropplero G, Mazloum M, Bienaimé F, Descroix S, et al. Decoupling shear stress and pressure effects in the biomechanics of autosomal dominant polycystic kidney disease using a perfused kidney-on-chip. Acta Biomaterialia. 2025;197:326-338. doi:10.1016/j.actbio.2025.03.022
BibTeX
@article{Lapin2025,
author = {Lapin, Brice and Vandensteen, Jessica and Gropplero, Giacomo and Mazloum, Manal and Bienaimé, Frank and Descroix, Stéphanie and Coscoy, Sylvie},
title = {Decoupling shear stress and pressure effects in the biomechanics of autosomal dominant polycystic kidney disease using a perfused kidney-on-chip},
journal = {Acta Biomaterialia},
year = {2025},
volume = {197},
pages = {326--338},
doi = {10.1016/j.actbio.2025.03.022}
}
EUVIMED